Amanote Research
Register
Sign In
Albendazole for Lymphatic Filariasis
doi 10.1002/14651858.cd003753.pub2
Full Text
Open PDF
Abstract
Available in
full text
Date
January 26, 2004
Authors
Unknown
Publisher
John Wiley & Sons, Ltd
Related search
MDA—Lymphatic Filariasis
Tropical Medicine and Health
Environmental
Public Health
Infectious Diseases
Occupational Health
Frequency, Severity, and Costs of Adverse Reactions Following Mass Treatment for Lymphatic Filariasis Using Diethylcarbamazine and Albendazole in Leogane, Haiti, 2000
American Journal of Tropical Medicine and Hygiene
Medicine
Virology
Parasitology
Infectious Diseases
Semi Analytical Method for Solving Lymphatic Filariasis Epidemic Model
Journal of Applied Sciences and Environmental Management
Correction: Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals With HIV Co-Infection in Southwest-Tanzania
PLoS Neglected Tropical Diseases
Pharmacology
Public Health
Environmental
Toxicology
Infectious Diseases
Pharmaceutics
Occupational Health
Lymphatic Filariasis Control in Tanzania: Effect of Six Rounds of Mass Drug Administration With Ivermectin and Albendazole on Infection and Transmission
BMC Infectious Diseases
Infectious Diseases
Lymphatic Filariasis in Luangwa District, South-East Zambia
Parasites and Vectors
Parasitology
Infectious Diseases
Progress on Elimination of Lymphatic Filariasis in Sierra Leone
Parasites and Vectors
Parasitology
Infectious Diseases
Lymphatic Filariasis in India : Problems, Challenges and New Initiatives
Medical Journal Armed Forces India
Medicine
Evaluation of Wuchereria Bancrofti GST as a Vaccine Candidate for Lymphatic Filariasis
PLoS Neglected Tropical Diseases
Pharmacology
Public Health
Environmental
Toxicology
Infectious Diseases
Pharmaceutics
Occupational Health
